AKBM — Aker Biomarine ASA Share News
0.000.00%
Last trade - 00:00- NOK8.68bn
- NOK10.43bn
- $218.10m
Norway's Aker BioMarine Q1 revenue rises 13% on record krill oil sales
Brief: Aker Biomarine Q1 Adjusted EBITDA $12.5 Mln
Norway's Aker BioMarine exploring alternatives for Human Health Ingredient unit
Brief: Aker BioMarine Q4 Adjusted EBITDA USD 10.6 Million
Brief: Aker BioMarine Q3 Adjusted EBITDA USD 12.2 Million
Brief: Aker Biomarine Wins New Business For Superba Krill Oil
Brief: Aker BioMarine Q2 Adjusted EBITDA USD 13.6 Million
Brief: Aker BioMarine Q1 Adjusted EBITDA USD 9 Million
Brief: Aker Biomarine Q4 Revenue Is $52.0 Mln
Brief: Aker BioMarine Q4 Adjusted EBITDA USD 7.4 Million
Brief: Aker BioMarine Q3 Adjusted EBITDA USD 8.4 Million
Brief: Aker Biomarine Completes Feed Ingredients Transaction, Distributes Dividend
Brief: Aker Biomarine Successfully Completes New Bond Issue
Brief: Aker Biomarine Q2 Adjusted EBITDA Of $29.0 Million
Brief: Aker BioMarine Q1 Adjusted EBITDA USD 15.2 Million
Brief: Aker BioMarine Q4 Adjusted EBITDA USD 17.6 Million Vs. IBES Estimate USD 20 Million
Brief: Aker Biomarine Receives Purchase Order
Brief: Aker Biomarine Q3 Adjusted EBITDA At USD 24.9 Mln
Brief: Aker Biomarine Acquires Patents, Equipment, And Scientific Data From Acasti Pharma